SCHEMBL13696399

SCHEMBL13696399

CCCCOCC1OC(c2ccc[nH]2)[C@](C)(OCCCC)[C@@H]1OCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9912319 1.00 — —
SCHEMBL9912340 0.81 HIF1A (0.32) —
SCHEMBL9912322 0.81 HIF1A (0.32) —
SCHEMBL13696397 0.81 HIF1A (0.32) —
SCHEMBL9912342 0.81 HIF1A (0.32) —
SCHEMBL13392126 0.77 — —
SCHEMBL12000784 0.74 SMN1; SMN2 (0.36) —
SCHEMBL11924464 0.73 — —
SCHEMBL13696402 0.73 — —
SCHEMBL9912326 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227524-A1 ANTIVIRAL THERAPEUTIC AGENTS BIOCRYST PHARMACEUTICALS, INC. (US) 2009-09-10 — — US disclosed
Send feedback